drugset / Trial / NCT00906035

The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)

NCT00906035

RandomizedParallel-groupTriple-blindTreatment

Summary

This research study will evaluate the effects of aspirin and dipyridamole alone and in combination on the blood flow in the vessels of the legs. We will examine how these medications are able to inhibit the clotting of platelets in the vessels of patients with PAD, and thereby affect the blood flow in the legs. Platelets are cells in the blood that have the ability to adhere to each other to form clots.

Timeline

Start
2002-09
Primary completion
2010-03
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 25 mg
Comparator Dipyridamole Other / unclassified 200 mg